Athens Medical C.S.A. Cash Flow Conversion Efficiency
Athens Medical C.S.A. cash flow conversion efficiency. Based on the latest financial reports, Athens Medical C.S.A. (IATR) has a cash flow conversion efficiency ratio of 0.029x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€3.17 Million ≈ $3.71 Million USD) by net assets (€108.78 Million ≈ $127.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Athens Medical C.S.A. (2014–2024)
Cash flow conversion efficiency of Athens Medical C.S.A. from 2014 to 2024. This chart illustrates how Athens Medical C.S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Athens Medical C.S.A. for real-time trading data and today's change.
Athens Medical C.S.A. Cash Flow Conversion Ratio Explained
Athens Medical C.S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Athens Medical C.S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Athens Medical C.S.A. ranked by their cash flow conversion efficiency. Also see IATR market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CI Games SA
WAR:CIG
|
0.095x |
|
Wellcall Holdings Bhd
KLSE:7231
|
0.095x |
|
D O Green Technologies Bhd
KLSE:7204
|
0.022x |
|
D-Box Technologies Inc.
TO:DBO
|
0.058x |
|
CVC Ltd
AU:CVC
|
0.234x |
|
Hsing Ta Cement Co Ltd
TW:1109
|
0.042x |
|
ANDREW PELLER LTD A
F:ANJ
|
0.013x |
|
DongKook Pharmaceutical Co. Ltd
KQ:086450
|
0.040x |
Annual Cash Flow Conversion Efficiency for Athens Medical C.S.A. (2014–2024)
The table below shows the annual cash flow conversion efficiency of Athens Medical C.S.A. from 2014 to 2024. Review IATR free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €108.81 Million ≈ $127.21 Million |
€46.44 Million ≈ $54.30 Million |
0.427x | +77.67% |
| 2023-12-31 | €108.77 Million ≈ $127.16 Million |
€26.13 Million ≈ $30.55 Million |
0.240x | +19904.30% |
| 2022-12-31 | €103.25 Million ≈ $120.71 Million |
€124.00K ≈ $144.97K |
0.001x | -99.22% |
| 2021-12-31 | €102.06 Million ≈ $119.32 Million |
€15.75 Million ≈ $18.41 Million |
0.154x | -66.59% |
| 2020-12-31 | €87.07 Million ≈ $101.79 Million |
€40.21 Million ≈ $47.01 Million |
0.462x | +15.96% |
| 2019-12-31 | €79.08 Million ≈ $92.46 Million |
€31.50 Million ≈ $36.82 Million |
0.398x | +42.46% |
| 2018-12-31 | €71.62 Million ≈ $83.73 Million |
€20.02 Million ≈ $23.41 Million |
0.280x | +1258.18% |
| 2017-12-31 | €63.18 Million ≈ $73.87 Million |
€-1.52 Million ≈ $-1.78 Million |
-0.024x | -114.98% |
| 2016-12-31 | €60.65 Million ≈ $70.91 Million |
€9.78 Million ≈ $11.43 Million |
0.161x | -26.39% |
| 2015-12-31 | €58.85 Million ≈ $68.80 Million |
€12.89 Million ≈ $15.07 Million |
0.219x | +350.93% |
| 2014-12-31 | €73.81 Million ≈ $86.29 Million |
€3.58 Million ≈ $4.19 Million |
0.049x | -- |
About Athens Medical C.S.A.
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and … Read more